Immunohistochemical expression of Survivin and its relationship with cell apoptosis and proliferation in ameloblastomas

Disease Markers

Volumn 2015, Issue , 2015, Pages

  González González, Rogelio ^a,b   Molina Frechero, Nelly ^c   Damian Matsumura, Pablo ^d   Salazar Rodriguez, Sirced ^e,f   Bologna Molina, Ronell ^a,g  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^d DEPARTAMENTO DE QUÍMICA   (Mexico)

^e Society for the Fight Against Cancer   (Ecuador)

^f INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^g UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; TUMOR MARKER;

ACANTHOMATOUS AMELOBLASTOMA; AMELOBLASTOMA; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CELL COUNT; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLICULAR AMELOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRALUMINAL UNICYSTIC AMELOBLASTOMA; LUMINAL UNICYSTIC AMELOBLASTOMA; MURAL UNICYSTIC AMELOBLASTOMA; PLEXIFORM AMELOBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH; UNICYSTIC AMELOBLASTOMA; GENETICS; METABOLISM; MOUTH TUMOR; PATHOLOGY;

AMELOBLASTOMA; APOPTOSIS; BIOMARKERS, TUMOR; CELL PROLIFERATION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MOUTH NEOPLASMS;

EID: 84926500688     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/301781     Document Type: Article

References (34)

1. H. Kumamoto and K. Ooya, "Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in amelo-blastomas", Virchows Archiv, Vol. 444, no. 2, pp. 164-170, 2004.
2. L. R. Eversole, "Malignant epithelial odontogenic tumors", Seminars in Diagnostic Pathology, Vol. 16, no. 4, pp. 317-324, 1999.
3. D. G. Gardner, K. Heikinheimo, M. Shear, H. P. Philipsen, and H. Coleman, "Ameloblastomas", in Pathology and Genetics of Head and Neck Tumours, J. W. Eveson, P. Reichart, and D. Sidransky, Eds., pp. 296-300, World Health Organization Clasification of Tumours, IARC Press, Lyon, France, 2005.
4. J. C. Reed, "Dysregulation of apoptosis in cancer", Journal of Clinical Oncology, Vol. 17, no. 9, pp. 2941-2953, 1999.
5. T. T. Renault, O. Teijido, B. Antonsson, L. M. Dejean, and S. Manon, "Regulation of Bax mitochondrial localization by Bcl-2 and Bcl-x L: keep your friends close but your enemies closer", International Journal of Biochemistry and Cell Biology, Vol. 45, no. 1, pp. 64-67, 2013.
6. O. Stasikowska-Kanicka, M. Wagrowska-Danilewicz, and M. Danilewicz, "Immunohistochemical study on survivin in sinonasal tumors and its relationship with the immunoexpression of Ki67 and Bcl-2", Folia Histochemica et Cytobiologica, Vol. 51, no. 3, pp. 225-231, 2013.
7. Q. L. Deveraux and J. C. Reed, "IAP family proteins: suppressors of apoptosis", Genes and Development, Vol. 13, no. 3, pp. 239-252, 1999.
8. C. Adida, P. L. Crotty, J. McGrath, D. Berrebi, J. Diebold, and D. C. Altieri, "Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation", The American Journal of Pathology, Vol. 152, no. 1, pp. 43-49, 1998.
9. N. K. Sah, Z. Khan, G. J. Khan, and P. S. Bisen, "Structural, functional and therapeutic biology of survivin", Cancer Letters, Vol. 244, no. 2, pp. 164-171, 2006.
10. J. A. Rodríguez, S. W. Span, C. G. M. Ferreira, F. A. E. Kruyt, and G. Giaccone, "CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin", Experimental Cell Research, Vol. 275, no. 1, pp. 44-53, 2002.
11. O. Stasikowska-Kanicka, M. Wagrowska-Danilewicz, and M. Danilewicz, "Immunohistochemical study on survivin in sinonasal tumors and its relationship with the immunoexpression of Ki67 and Bcl-2", Folia Histochemica et Cytobiologica, Vol. 51, no. 3, pp. 225-231, 2013.
12. L. L. Loro, O. K. Vintermyr, and A. C. Johannessen, "Apoptosis in normal and diseased oral tissues", Oral Diseases, Vol. 11, no. 5, pp. 274-287, 2005.
13. H. Kumamoto and K. Ooya, "Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas", Journal of Oral Pathology and Medicine, Vol. 34, no. 9, pp. 565-572, 2005.
14. A. Abdel-Aziz and M. M. Amin, "EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence", Diagnostic Pathology, Vol. 7, no. 1, article 14, 2012.
15. P. Sah, A. Menon, A. Kamath, C. Chandrashekar, S. Carnelio, and R. Radhakrishnan, "Role of immunomarkers in the clin-icopathological analysis of unicystic ameloblastoma", Disease Markers, Vol. 35, no. 5, pp. 481-488, 2013.
16. J. Gerdes, U. Schwab, H. Lemke, and H. Stein, "Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation", International Journal of Cancer, Vol. 31, no. 1, pp. 13-20, 1983.
17. J. Gerdes, H. Lemke, and H. Baisch, "Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67", The Journal of Immunology, Vol. 133, no. 4, pp. 1710-1715, 1984.
18. T. Scholzen and J. Gerdes, "The Ki-67 protein: from the known and the unknown", Journal of Cellular Physiology, Vol. 182, no. 3, pp. 311-322, 2000.
19. C. Ledesma-Montes, A. Mosqueda-Taylor, R. Carlos-Bregni et al., "Ameloblastomas: a regional Latin-American multicentric study", Oral Diseases, Vol. 13, no. 3, pp. 303-307, 2007.
20. R. Bologna-Molina, A. Mosqueda-Taylor, E. Lopez-Corella et al., "Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas", Oral Oncology, Vol. 44, no. 8, pp. 805-811, 2008.
21. K. Dhanuthai, S. Chantarangsu, S. Rojanawatsirivej et al., "Amelo-blastoma: a multicentric study", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 113, no. 6, pp. 782-788, 2012.
22. C. C. Gomes, A. P. Duarte, M. G. Diniz, and R. S. Gomez, "Current concepts of ameloblastoma pathogenesis: review article", Journal of Oral Pathology and Medicine, Vol. 39, no. 8, pp. 585-591, 2010.
23. D. M. Hockenbery, M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer, "Bcl2 protein is topographically restricted in tissues characterized by apoptotic cell death", Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, no. 16, pp. 6961-6965, 1991.
24. F. Sandra, N. Nakamura, T. Mitsuyasu, Y. Shiratsuchi, and M. Ohishi, "Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre)", Histopathology, Vol. 39, no. 1, pp. 93-98, 2001.
25. G. Ambrosini, C. Adida, and D. C. Altieri, "A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma", Nature Medicine, Vol. 3, no. 8, pp. 917-921, 1997.
26. G. Qi, Y. Kudo, T. Ando et al., "Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B", Oral Oncology, Vol. 46, no. 4, pp. 263-270, 2010.
27. L. Sui, Y. Dong, M. Ohno, Y. Watanabe, K. Sugimoto, and M. Tokuda, "Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.", International journal of oncology, Vol. 21, no. 2, pp. 315-320, 2002.
28. C. Jane, A. V. Nerurkar, N. V. Shirsat, R. B. Deshpande, A. D. Amrapurkar, and F. R. Karjodkar, "Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers", Journal of Oral Pathology and Medicine, Vol. 35, no. 10, pp. 595-601, 2006.
29. G. Marioni, A. Bedogni, L. Giacomelli et al., "Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas", Acta Oto-Laryngologica, Vol. 125, no. 11, pp. 1218-1223, 2005.
30. M. Soluk Tekkeşin, S. Mutlu, and V. Olgaç, "Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic odontogenic tumor) in comparison with ameloblastomas and radicular cysts", Turkish Journal of Pathology, Vol. 28, no. 1, pp. 49-55, 2012.
31. T. Mitsuyasu, H. Harada, Y. Higuchi et al., "Immunohistochemical demonstration of bcl-2 protein in ameloblastoma", Journal of Oral Pathology and Medicine, Vol. 26, no. 8, pp. 345-348, 1997.
32. L. Lalier, P.-F. Cartron, P. Juin et al., "Bax activation and mitochondrial insertion during apoptosis", Apoptosis, Vol. 12, no. 5, pp. 887-896, 2007.
33. S. Meer, J. S. Galpin, M. Altini, H. Coleman, and H. Ali, "Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas", Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, Vol. 95, no. 2, pp. 213-221, 2003.
34. T. Rosenstein, M. A. Pogrel, R. A. Smith, and J. A. Regezi, "Cystic ameloblastoma-behavior and treatment of 21 cases", Journal of Oral and Maxillofacial Surgery, Vol. 59, no. 11, pp. 1311-1316, 2001.